Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Marken Prepares for Growth In China | Contract Pharma

What are you searching for?

Sign in
Breaking News

Marken Prepares for Growth In China

Receives extended license, expands infrastructure and staff

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Marken has been granted a 12-year license to ship biological samples and drug product within China. The company has also grown its presence in China, adding staff trained and certified on IATA regulations and anti-corruption policies. Marken has also initiated its Phase II depot roll out plan with the construction of its pharmaceutical depot near the Beijing International airport.
 
Wes Wheeler, chief executive officer of Marken, said, “We recognize the value of the clinical trial market in Asia and what economic impact the region has for many of our pharmaceutical clients. China, Korea and Japan are now clearly in focus for Marken and we will continue to analyze and anticipate new opportunities, both within China as well as other parts of Asia and the world as a whole.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters